Omnicell to purchase MACH4 Pharma Systems
Omnicell said it expects the acquisition to close in the first or second quarter of this year. The acquisition is subject to certain closing conditions set forth in the purchase agreement.
After the acquisition is complete, Omnicell and MACH4 will create a comprehensive automated medication-management system for hospital and retail pharmacies in Europe and other international markets.
“Omnicell is committed to providing a complete set of pharmacy-automation solutions that increase efficiencies and promote patient safety in hospitals and long-term care and retail settings, and to taking our global presence to a new level,” Randall Lipps -- chairman, president and CEO of Omnicell -- said. “With MACH4, the expanded Omnicell portfolio will include innovative solutions that span robotic medication management systems, automated dispensing cabinets and medication-adherence technology to meet the unique demands of our growing base of customers worldwide to provide services across the continuum of care.”
The expected revenue contributions from MACH4 will be between $12 million and $15 million, with non-GAAP earnings-per-share dilution of approximately 4 cents, Omnicell said.